Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Cell Biochem Biophys ; 82(2): 1511-1521, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38771457

RESUMO

The Wnt signaling pathway is identified as one of the main disrupted pathways in Colorectal cancer (CRC). Results from studies focusing on this route will aid greatly in the detection and treatment of CRC. MicroRNAs (MiRs), particularly MiR-490, has emerged as key regulator of gene expression in biological pathways, making it an attractive research target. This is notably true for the Wnt signaling pathway, which is usually disordered in CRC tissues. This study aimed to evaluate the expression level of MiR-490 isomiRs and determine some of its key target genes involved in Wnt signaling pathway in CRC tissues and cell lines, based on experimental and bioinformatics analysis. Elevated expression of GSK3ß and CCND1 indicate that the progression of CRC tumor is associated with the inhibitory effect of MiR-490 isomiRs on the Wnt/ß-catenin signaling pathway. This finding was supported by the observation of a positive connection between the expression pattern of miR-490-3p and 5p, and CCND1 and GSK3ß in CRC. The valuable results of this study provide a means of identifying biomarkers with the potential to either inhibit or activate CRC cellular pathways.


Assuntos
Neoplasias Colorretais , Ciclina D1 , Glicogênio Sintase Quinase 3 beta , MicroRNAs , Via de Sinalização Wnt , MicroRNAs/genética , MicroRNAs/metabolismo , Humanos , Glicogênio Sintase Quinase 3 beta/metabolismo , Glicogênio Sintase Quinase 3 beta/genética , Neoplasias Colorretais/metabolismo , Neoplasias Colorretais/genética , Neoplasias Colorretais/patologia , Ciclina D1/metabolismo , Ciclina D1/genética , Linhagem Celular Tumoral , Regulação Neoplásica da Expressão Gênica
2.
J Biomater Appl ; 37(7): 1137-1158, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-36066191

RESUMO

Today, nanobiotechnology is a pioneering technology in biomedicine. Every day, new nanomaterials are synthesized with elevated physiochemical properties for better diagnosis and treatment of diseases. One advancing class of materials is the Graphene family. Among different kinds of graphene derivatives, graphene quantum dots (GQDs) show fantastic optical, electrical, and electrochemical features originating from their unique quantum confinement effect. Due to the distinct properties of GQD, including large surface-to-volume ratio, low cytotoxicity, and easy functionalization, this nanomaterial has gone popular in biomedical field. Herein, a short overview of different strategies developed for GQD synthesis and functionalization is discussed. In the following, the most recent progress of GQD based nanomaterials in different biomedical fields, including bio-imaging, drug/gene delivery, antimicrobial, tissue engineering, and biosensors, are reviewed.


Assuntos
Técnicas Biossensoriais , Grafite , Nanoestruturas , Pontos Quânticos , Grafite/química , Pontos Quânticos/química , Nanoestruturas/química , Técnicas Biossensoriais/métodos , Terapia Genética
3.
Biomed Pharmacother ; 144: 112353, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34794240

RESUMO

Almost 80% of people confronting COVID-19 recover from COVID-19 disease without any particular treatments. They experience heterogeneous symptoms; a wide range of respiratory symptoms, cough, dyspnea, fever, and viral pneumonia. However, some others need urgent intervention and special treatment to get rid of this widespread disease. So far, there isn't any unique drug for the potential treatment of COVID 19. However, some available therapeutic drugs used for other diseases seem beneficial for the COVID-19 treatment. On the other hand, there is a robust global concern for developing an efficient COVID-19 vaccine to control the COVID-19 pandemic sustainably. According to the WHO report, since 8 October 2021, 320 vaccines have been in progress. 194 vaccines are in the pre-clinical development stage that 126 of them are in clinical progression. Here, in this paper, we have comprehensively reviewed the most recent and updated information about coronavirus and its mutations, all the potential therapeutic approaches for treating COVID-19, developed diagnostic systems for COVID- 19 and the available COVID-19 vaccines and their mechanism of action.


Assuntos
Tratamento Farmacológico da COVID-19 , Vacinas contra COVID-19/uso terapêutico , COVID-19/prevenção & controle , Técnicas Biossensoriais/métodos , COVID-19/diagnóstico , Teste de Ácido Nucleico para COVID-19/métodos , Dexametasona/uso terapêutico , Glucocorticoides/uso terapêutico , Humanos , Técnicas de Diagnóstico Molecular/métodos , Mutação , Técnicas de Amplificação de Ácido Nucleico/métodos , Testes Imediatos , SARS-CoV-2/genética , Organização Mundial da Saúde
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA